<DOC>
	<DOCNO>NCT02133950</DOCNO>
	<brief_summary>A single centre observational study segmentation preimplantation genetic diagnosis ( PGD ) treatment compare cumulative pregnancy rate follow cryopreservation genetically transferable embryo PGD , compare fresh embryo transfer cumulative frozen embryo transfer genetically transferable embryos.The primary aim study assess feasibility effectiveness segmentation term pregnancy rate . The secondary aim ass logistic advantage segmentation PGD cycle . Experimental question 1 . Is cumulative live birth rate rate single PGD treatment genetically transferable embryo cryopreserved vitrification prior consecutive utero transfer unstimulated cycle , superior PGD treatment fresh embryo transfer cumulative transfer supernumerary cryopreserved embryos ? 2 . Does technique segmentation allow good planning DNA amplification genetic analysis ? Design The propose design pragmatic , prospective randomise control trial</brief_summary>
	<brief_title>Efficacy Study Segmentation PGD Treatment</brief_title>
	<detailed_description />
	<criteria>1st , 2nd 3rd cycle PGD embryo transfer perform Indications PGD : monogenic indication Xlinked disorder 2550 % risk transmission associate reduced ovarian response Normal ultrasound scan , i.e . presence ovary , without evidence abnormality within 6 month prior randomisation . Regular menstrual cycle 2135 day , presumed ovulatory . POLYCYSTIC OVARIAN SYNDROME ( Rotterdam criterion * ) * At least two follow three feature : ( ) Oligo and/or anovulation ( ii ) Clinical and/or biochemical sign hyperandrogenism ( iii ) Polycystic ovary exclusion aetiology ( congenital adrenal hyperplasia , androgensecreting tumour , Cushing 's syndrome ) Poor responder ( Bologna criterion ** ) * * At least two follow three feature : ( ) Advanced maternal age ( ≥40 year ) risk factor poor ovarian response ( POR ) ; ( ii ) A previous POR ( ≤3 oocytes conventional stimulation protocol ) ; ( iii ) An abnormal ovarian reserve test ( i.e . antral follicle count ( AFC ) 57 follicle , antiMullerian hormone ( AMH ) 0.51.1 ng/ml ) . Endocrine metabolic abnormality ( pituitary , adrenal , pancreas , liver kidney ) anticipate high response : AMH &gt; 5.0 ng/ml AFC &gt; 20 Endometriosis ≥ grade 3 Age &gt; 40 year 364 day</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>preimplantation genetic diagnosis</keyword>
	<keyword>cryopreservation</keyword>
	<keyword>pregnancy</keyword>
</DOC>